GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Neurosurgical Holding Inc (OTCPK:USNU) » Definitions » Price-to-Free-Cash-Flow

US Neurosurgical Holding (US Neurosurgical Holding) Price-to-Free-Cash-Flow : N/A (As of Jun. 09, 2024)


View and export this data going back to . Start your Free Trial

What is US Neurosurgical Holding Price-to-Free-Cash-Flow?

As of today (2024-06-09), US Neurosurgical Holding's share price is $0.5961. US Neurosurgical Holding's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.12. Hence, US Neurosurgical Holding's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for US Neurosurgical Holding's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, US Neurosurgical Holding's highest Price-to-Free-Cash-Flow Ratio was 45.45. The lowest was 0.53. And the median was 1.49.

USNU's Price-to-Free-Cash-Flow is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 16.68
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

US Neurosurgical Holding's Free Cash Flow per Share for the three months ended in Mar. 2024 was $-0.04. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.12.

During the past 13 years, US Neurosurgical Holding's highest 3-Year average Free Cash Flow per Share Growth Rate was 42.90% per year. The lowest was -53.60% per year. And the median was 0.50% per year.


US Neurosurgical Holding Price-to-Free-Cash-Flow Historical Data

The historical data trend for US Neurosurgical Holding's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Neurosurgical Holding Price-to-Free-Cash-Flow Chart

US Neurosurgical Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 1.89 10.45 - -

US Neurosurgical Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of US Neurosurgical Holding's Price-to-Free-Cash-Flow

For the Medical Care Facilities subindustry, US Neurosurgical Holding's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


US Neurosurgical Holding's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US Neurosurgical Holding's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where US Neurosurgical Holding's Price-to-Free-Cash-Flow falls into.



US Neurosurgical Holding Price-to-Free-Cash-Flow Calculation

US Neurosurgical Holding's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.5961/-0.119
=N/A

US Neurosurgical Holding's Share Price of today is $0.5961.
US Neurosurgical Holding's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

US Neurosurgical Holding  (OTCPK:USNU) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


US Neurosurgical Holding Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of US Neurosurgical Holding's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


US Neurosurgical Holding (US Neurosurgical Holding) Business Description

Traded in Other Exchanges
N/A
Address
2400 Research Boulevard, Suite 325, Rockville, MD, USA, 20850
US Neurosurgical Holding Inc operates as a holding company in United State. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.
Executives
Lawrence William St director 23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler director 43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii director
Alan Gold director, 10 percent owner, officer: President & Chairman 2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman 10 percent owner C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc 10 percent owner 711 FIFTH AVENUE, NEW YORK NY 10022

US Neurosurgical Holding (US Neurosurgical Holding) Headlines

No Headlines